QS Research · Michael Burry's Scion Capital analyst template · 2006
WATERS CORP /DE/ (WAT)
As of 2026-11-17 · 12/15 boxes filled from SEC filings and market data
Report price $453.42 (close 2026-11-16); latest close $440.45 (2026-11-20), -2.9% since the report; figures re-marked at the latest close
Conclusion: AVOID
Conviction medium · base case -41% · downside -56% · upside +20%
The market is pricing 43.6x TTM GAAP EBITDA and 8.75x TTM sales, with a reverse DCF requiring +30.7% revenue growth a year for ten years against +7.0% in the latest fiscal year. This is an AVOID: ROIC of 1.2% sits 6.9 points below the 8.1% WACC, FCF yield is 0.7%, and the earnings power does not cover the capital cost. The base case is -42.7% to $259.76 at EV/EBITDA of 26.7x, the peer median EV/EBITDA. The downside is -57.0% to $194.82 on the base case's multiple on -25.0% earnings (the peers trade below the compressed multiple). The upside is +16.5% to $528.36 on +15% earnings at today's EV/EBITDA of 43.6x. Fundsmith LLP holds 7.7% of its 13F book and trimmed at 2026-09-30; the call disagrees with that consensus premium because the cited ROIC-WACC spread, FCF yield and reverse-DCF growth requirement leave no room for the multiple to hold, and 13F holdings are as of the quarter end.
Key numbers
- Share price: $440.45
- Market cap: $43.29B
- Latest financial period: TTM to Oct 3, 2026
- Revenue (TTM): $5.61B
- EV / EBITDA (TTM): 42.5x
- P/E (TTM): 438.9x
- FCF yield: 0.7%
- Price / book: 2.83x
- Earnings-quality flags (TTM): Restructuring charges -$60.0M (61% of net income)
- P/E, adjusted (TTM): 272.9x
- P/E, operating (tax-normalized) (TTM): 581.4x
- EV / FCF (TTM): 164.5x
- Revenue growth (latest fiscal year): +7.0%
- ROIC (TTM): 1.2%
- WACC: 8.0%
- Economic profit spread: -6.9 pts
- EV / EBITDA sanity: 1
The 15 boxes
- ✓ 1. Long-form business notes
Waters makes money selling and servicing liquid chromatography, mass spectrometry and thermal-analysis instruments, columns/consumables, software and post-warranty service plans. The FY2025 10-K shows a $3.17B revenue base before the February 2026 BDS acquisition; that $16.8B deal added diagnostics and biosciences businesses and reorganized the company into four segments. The TTM to 2026-10-03 is post-deal at $5.61B revenue, but operating income and net income to common are much lower than FY2025, with $733.0M of TTM intangible amortization. The oldest FY2020 10-K shows a smaller two-segment Waters/TA business; the latest report shows a larger, re-segmented company after Wyatt and BDS.
- ✓ 2. Competitive advantage
Waters' stated advantage is technical, not price: it says it competes on product performance, reliability and service and only "to a lesser extent, price", and that it is one of few suppliers that processes silica and polymeric resins, packs columns and distributes its own products. The earnings record through FY2025 does not show that advantage turning into operating leverage: operating income was $873.4M in FY2022 versus $802.6M in FY2025 while revenue rose from $2.97B to $3.17B. The post-deal picture is a different company: TTM to 2026-10-03 revenue is $5.61B but GAAP operating income is only $264.6M after $733.0M of intangible amortization, with diluted shares up from 59.71M (FY2025) to 92.71M. Cash generation has been consistently real (operating cash flow $602.8M-$790.5M each year FY2020-FY2025) but eased to $479.6M in the TTM period, and the company now competes against larger, better-funded rivals with $4.0B of assumed SpinCo debt.
- ✓ 3. 10-Q takeaways
Q3 2026 revenue jumped 121% to $1.767 billion, but almost all of the step-up was the acquired BDS Business; legacy organic revenue grew 9% as reported and 10% in constant currency. GAAP operating margin fell to 7.2% on purchase-accounting amortization, inventory/fixed-asset step-up and deal/restructuring costs, while segment operating income was $578 million, or 32.7% of revenue, and adjusted EPS rose 21% to $4.10. Nine-month operating cash flow fell to $315 million from $488 million, the company made no open-market buybacks, and full-year 2026 revenue and adjusted EPS guidance was raised. The 10-Q says risk factors did not materially change from the FY2025 10-K, though the computed 10-K diff shows new integration, restructuring and indebtedness risk language.
- ✓ 4. Corporate governance
Filled; members read this box.
- ✓ 5. Overview of the prior 3 years of 8-K filings
Filled; members read this box.
- ✓ 6. Other significant filings
Filled; members read this box.
- ✓ 7. Chronology of significant news and events
Filled; members read this box.
- ✓ 8. Comparables valuation interpretation
Filled; members read this box.
- ✓ 9. Insider trading interpretation
Filled; members read this box.
- ○ 10. Earnings-call notes
- ○ 11. Impression of the shareholder letter
- ○ 12. Scuttlebutt overview
- ✓ 13. Valuation and risk/reward summary
Filled; members read this box.
- ✓ 14. Current price suppression and potential catalysts
Filled; members read this box.
- ✓ 15. Conclusions
The call above.
Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.